Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular docking

Author:

Li Qian1ORCID,Chai Yihui1,Li Wen1,Guan Liancheng2,Fan Yizi3,Chen Yunzhi1

Affiliation:

1. Guizhou University of Traditional Chinese Medicine, Guiyang City, China

2. The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang City, China

3. Chongqing High-tech Zone People’s Hospital, Chongqing City, China.

Abstract

To explore the molecular mechanism of Simiao Decoction (SMD) intervening atherosclerosis (AS). The main components and potential mechanisms of SMD remain unknown. This study aims to initially clarify the potential mechanism of SMD in the treatment of AS based on network pharmacology and molecular docking techniques. The principal components and corresponding protein targets of SMD were searched on Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and the compound-target network was constructed by Cytoscape3.9.1. AS targets were searched on DrugBank, OMIM, and TTD databases. The intersection of compound target and disease target was obtained and the coincidence target was imported into STRING database to construct a protein–protein interaction network. We further performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis on the targets. The molecular docking method was used to verify the interaction between core components of SMD and targets. We created the active compounds-targets network and the active compounds-AS-targets network based on the network database containing Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, DrugBank, OMIM, and TTD. We discovered that the therapy of AS with SMD involves 3 key substances—quercetin, kaempferol, and luteolin—as well as 5 crucial targets—ALB, AKT1, TNF, IL6, and TP53. The Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed that the shared targets involved a number of signaling pathways, including the advanced glycosylation end product-receptor of AGE signaling pathway in diabetic complications, Hepatitis B, Lipid and atherosclerosis, Chemical Carcinogenesis-Receptor Activation, and Pathways in Cancer. The molecular docking demonstrated that the binding energies of quercetin, kaempferol, and luteolin with 5 important targets were favorable. This study reveals the active ingredients and potential molecular mechanism of SMD in the treatment of AS, and provides a reference for subsequent basic research.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference45 articles.

1. Pathogenesis of atherosclerosis.;Falk;J Am Coll Cardiol,2006

2. The pathogenesis of atherosclerosis: a perspective for the 1990s.;Ross;Nature,1993

3. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.;Perrotta;Vascul Pharmacol,2019

4. Perceived stress level is associated with coronary artery disease severity in patients with ST-segment elevation myocardial infarction.;Kahraman;Turk Kardiyol Dern Ars,2020

5. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke.;Tuttolomondo;Atherosclerosis,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3